Search results

See details of previously published customer updates from our Health products team. 

ANSTO is working with academic and industry partners on the development of multiscale numerical simulations of Laser Metal Deposition (LMD) 3D printing.

Congress marks watershed moment for nuclear medicine and ANSTO

The ANSTO Awards in Nuclear Science and Technology 2018 were presented on Friday 2 November at The Australian Museum, and showcased ANSTO’s unique nuclear science and technology capabilities, which enable progress in the key areas of health research and innovation for industry.

Project Bright, the construction of eight new beamlines at ANSTO’s Australian Synchrotron has reached a milestone by achieving ‘First Light’ for the new micro-computed tomography (MCT) beamline in late NovembeR.

ANSTO has put together a robust multidisciplinary approach to understanding the impacts of nanomaterials, investigating a common food additive, E171 titanium dioxide, used primarily as a colouring agent in everyday foods. 

View the upcoming proposal deadlines for access to ANSTO’s Research Portal. The User Office provides support for research proposals and enables you to leverage our world-class research infrastructure and facilities.

Study explored how key proteins manage dietary cholesterol absorption and elucidated crucial transport mechanisms that contribute to cholesterol balance in the body.

ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.

Specifications, Beryllium Filter, User Manual, Instrument reference